← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ingenious Targeting Laboratory, Inc.
Stonybrook, NY
$4,497,162
Total funding
5
Grants
Funding over time
peak $1.3M · FY2018–24$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,497,162 · 5
By mechanism
R44$2,990,687 · 1
R43$1,506,475 · 4
Investigators at Ingenious Targeting Laboratory, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies$998,985
R44 · FY2022 · AI
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies$996,252
R44 · FY2024 · AI
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies$995,450
R44 · FY2023 · AI
Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19$297,204
R43 · FY2021 · AI
Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19$292,710
R43 · FY2022 · AI
A Novel Small Animal Model as a Source of Therapy-Bound Single-Chain Antibody Products$279,546
R43 · FY2018 · AI
A Novel Small Animal Model as a Source of Therapy-Bound Single-Chain Antibody Products$257,655
R43 · FY2019 · AI
Genetic Modification of the Rabbit for Development of Single Chain Antibodies$224,850
R43 · FY2019 · AI
New tool for insertional mutagenesis in the mouse$99,510
R43 · FY2003 · CA
Business Potential of a Novel Small Animal Model and its Single-Chain Antibodies$55,000
R43 · FY2020 · AI